June 24, 2020 / 1:22 AM / 20 days ago

BRIEF-Pharmaust Says Monepantel, Monepantel Sulfone Treatment Reduce COVID-19 Cell-To-Cell Infectivity

June 24 (Reuters) - Pharmaust Ltd:

* MONEPANTEL & MONEPANTEL SULFONE TREATMENT BOTH REDUCE SARS-COV-2 CELL-TO-CELL INFECTIVITY IN CELL CULTURE

* VIRUS INFECTIVITY WAS SUPRESSED BY APPROXIMATELY 95% IN CELL CULTURE IN TESTS

* QUANTITIES OF MONEPANTEL REQUIRED TO INHIBIT COVID-19 VIRUS INFECTIVITY WERE IN CLINICALLY ACCEPTABLE RANGE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below